CANbridge Life Sciences Raises $25 Million in Series B Round Led by Lapam Capital
May 23, 2017
CANbridge Life Sciences and Amoy Diagnostics Announced that They Have Entered into a Strategic Partnership to Develop a Companion Diagnostic Assay for Canbridge’s Lead Candidate, CAN008, a Fully Human FC Fusion Protein.
May 08, 2017
CANbridge Life Sciences Awarded “Deal of the Year 2016 ”by China Healthcare Investment Conference for License of Cancer Candidate from AVEO
Mar 31, 2017